MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,983,077 | -21.4% | 13,579 | +24.3% | 0.38% | -23.3% |
| Q2 2023 | $2,523,906 | +45.1% | 10,926 | +52.2% | 0.49% | +39.6% |
| Q1 2023 | $1,739,427 | -22.4% | 7,180 | -31.4% | 0.35% | -45.7% |
| Q3 2018 | $2,241,000 | +57.9% | 10,467 | +106.4% | 0.65% | +28.2% |
| Q2 2018 | $1,419,000 | – | 5,072 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |